What is the recommended dosing frequency of terbinafine for toe fungal infections (onychomycosis or tinea pedis)?

Terbinafine Dosing for Toe Fungal Infections

For toenail onychomycosis (fungal nail infection), prescribe terbinafine 250 mg orally once daily for 12 weeks; for tinea pedis (athlete's foot), prescribe terbinafine 250 mg orally once daily for 2–4 weeks. 1, 2, 3

Toenail Onychomycosis (Fungal Nail Infection)

Standard Dosing Regimen

• Terbinafine 250 mg once daily for 12 weeks is the gold-standard first-line treatment for dermatophyte toenail infections, with superior efficacy compared to all alternatives (complete cure rates of 55% vs 26% for itraconazole at 72 weeks). 1, 2, 4
• Extend treatment to 16 weeks for severe toenail disease with extensive nail involvement. 1, 2
• The medication can be taken with or without food. 2, 3

Critical Pre-Treatment Requirements

• Confirm mycological diagnosis with both microscopy (KOH) and fungal culture before prescribing—clinical diagnosis alone is unreliable and other conditions (psoriasis, trauma-related dystrophy) can mimic onychomycosis. 1, 2, 5
• Obtain baseline liver function tests (ALT, AST) and complete blood count before starting therapy, as hepatotoxicity can lead to liver failure requiring transplant or death. 1, 2, 3

Safety Monitoring During Treatment

• Instruct patients to immediately report persistent nausea, anorexia, fatigue, vomiting, right upper abdominal pain, jaundice, dark urine, or pale stools—discontinue terbinafine immediately if these occur. 2, 3
• Warn patients about taste disturbance (can be severe and permanent) and smell disturbance (may be prolonged or permanent)—discontinue if these develop. 2, 3
• Monitor for depressive symptoms (sadness, worthlessness, sleep changes, loss of interest) and discontinue if they emerge. 2, 3

Post-Treatment Follow-Up

• Re-evaluate 3–6 months after treatment completion with repeat mycological analysis (microscopy and culture) and clinical examination to assess cure. 1, 2, 4
• If disease persists, restart terbinafine 250 mg daily for the full 12-week duration without delay. 2
• If a second course fails, switch to itraconazole 200 mg daily for 12 weeks continuously, or 400 mg daily for 1 week per month for 3 cycles. 1, 2

Why Continuous Daily Dosing (Not Pulse Therapy)

• Pulse regimens are NOT recommended for terbinafine—they were developed for itraconazole based on its unique pharmacokinetics, and terbinafine is licensed only for continuous daily dosing. 2
• Although terbinafine persists in nail tissue for up to 30 weeks after stopping, this does not translate to equivalent efficacy with pulse dosing; sustained drug concentrations are required to maintain the very low minimum inhibitory concentration (0.004 μg/mL) needed for dermatophyte eradication. 2
• Research studies on pulse terbinafine show conflicting results, with some demonstrating inferior clinical cure rates (53.5% pulse vs 35% continuous for toenails, though mycological cure was similar). 6

---

Tinea Pedis (Athlete's Foot)

Topical Therapy (First-Line for Localized Disease)

• Topical terbinafine 1% cream applied once or twice daily for 1–4 weeks is the mainstay for superficial or localized tinea pedis. 7, 5, 8
• One week of topical terbinafine is as effective as 4 weeks of clotrimazole 1% cream, with faster symptom resolution. 9

Oral Therapy (Reserved for Specific Indications)

• Terbinafine 250 mg once daily for 2–4 weeks is indicated for:
  • Extensive disease not responding to topical treatment 5, 8
  • Concomitant toenail onychomycosis 8
  • Immunocompromised patients 5, 8
  • Hair follicle involvement (moccasin-type/hyperkeratotic tinea pedis) 5

Combined Therapy

• Combining topical and oral antifungals may increase cure rates in severe or refractory cases. 8

---

Special Populations

Pediatric Dosing (Weight-Based)

• < 20 kg: 62.5 mg daily 2, 10, 4
• 20–40 kg: 125 mg daily 2, 10, 4
• > 40 kg: 250 mg daily (adult dose) 2, 10, 4
• Treatment duration: 6 weeks for fingernails, 12 weeks for toenails 2, 10
• Terbinafine is unlicensed for pediatric use but remains the preferred oral agent due to superior efficacy over itraconazole (46% vs 13% long-term mycological cure in adults). 10

Diabetic Patients

• Terbinafine is preferred due to low hypoglycemia risk and minimal drug interactions (itraconazole is contraindicated in heart failure, which is more prevalent in diabetics). 4

Immunosuppressed Patients

• Terbinafine is preferred due to fewer interactions with antiretrovirals and immunosuppressive medications compared to azole antifungals. 4

---

Contraindications and Drug Interactions

Absolute Contraindications

• Active or chronic liver disease (requires avoidance of terbinafine). 2, 3
• History of allergic reaction to oral terbinafine (risk of anaphylaxis). 3

Important Drug Interactions

• Terbinafine inhibits CYP2D6 and affects metabolism of desipramine, cimetidine, fluconazole, cyclosporine, rifampin, and caffeine. 1, 3
• Use caution with antidepressants, antihypertensives, and cardiac medications. 3

---

Prevention of Recurrence

Footwear Decontamination

• Discard old, moldy footwear or decontaminate by placing naphthalene mothballs in shoes, sealing in a plastic bag for 3 days, then airing out. 1
• Apply antifungal powders (miconazole, clotrimazole, tolnaftate) inside shoes regularly, or spray terbinafine solution periodically. 1, 10

Hygiene Measures

• Wear protective footwear (sandals, water shoes) in public pools, gyms, and locker rooms. 1, 10
• Keep nails short and avoid sharing nail clippers with family members. 1, 10
• Treat all infected family members simultaneously to prevent reinfection. 1, 10